Defining the underlying defect in insulin action in type 2 diabetes

[1]  T. N. Rao,et al.  Leptin Receptor Signaling Regulates Protein Synthesis Pathways and Neuronal Differentiation in Pluripotent Stem Cells , 2020, Stem cell reports.

[2]  M. Mann,et al.  A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes. , 2020, Cell metabolism.

[3]  G. Shulman,et al.  A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance. , 2020, Cell metabolism.

[4]  V. M. V. Program.  Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis , 2020 .

[5]  T. Hansen,et al.  Skeletal muscle enhancer interactions identify genes controlling whole-body metabolism , 2020, Nature Communications.

[6]  Richard T. Lee,et al.  Arrestin domain-containing 3 (Arrdc3) modulates insulin action and glucose metabolism in liver , 2020, Proceedings of the National Academy of Sciences.

[7]  G. Shulman,et al.  The integrative biology of type 2 diabetes , 2019, Nature.

[8]  L. Groop,et al.  Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. , 2019, The lancet. Diabetes & endocrinology.

[9]  X. Bai,et al.  Author response: Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor–ligand complex , 2019 .

[10]  David Torrents,et al.  Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes , 2019, Nature Genetics.

[11]  B. Vanhaesebroeck,et al.  PI3K isoforms in cell signalling and vesicle trafficking , 2019, Nature Reviews Molecular Cell Biology.

[12]  Radhika S. Khetani,et al.  Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression , 2019, Cell.

[13]  M. Mann,et al.  FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism , 2019, Nature Communications.

[14]  N. Patel,et al.  Stabilization of lncRNA GAS5 by a Small Molecule and Its Implications in Diabetic Adipocytes. , 2019, Cell chemical biology.

[15]  C. Kahn,et al.  Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo. , 2019, Cell reports.

[16]  C. Kanduri,et al.  FOXK1 and FOXK2 regulate aerobic glycolysis , 2019, Nature.

[17]  J. Zierath,et al.  Circulating Exosomal miR-20b-5p Is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle , 2018, Diabetes.

[18]  C. Kahn,et al.  FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy , 2018, Diabetes.

[19]  F. Mancarella,et al.  MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes , 2018, International journal of molecular sciences.

[20]  C. Kahn,et al.  Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action. , 2018, Cellular signalling.

[21]  J. Blenis,et al.  mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-Dependent Foxk1 Phosphorylation. , 2018, Molecular cell.

[22]  Bridget Carragher,et al.  Structure of the Insulin Receptor-Insulin Complex by Single Particle CryoEM analysis , 2018, Nature.

[23]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[24]  S. A. Arriola Apelo,et al.  Restoration of metabolic health by decreased consumption of branched‐chain amino acids , 2017, The Journal of physiology.

[25]  Jong Bae Seo,et al.  Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity , 2017, Cell.

[26]  M. Lawrence,et al.  Insulin Receptor Isoforms in Physiology and Disease: An Updated View , 2017, Endocrine reviews.

[27]  H. Shimano,et al.  SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology , 2017, Nature Reviews Endocrinology.

[28]  Peter K. Davidsen,et al.  Dysregulation of a novel miR-23b/27b-p53 axis impairs muscle stem cell differentiation of humans with type 2 diabetes , 2017, Molecular metabolism.

[29]  A. Toker,et al.  AKT/PKB Signaling: Navigating the Network , 2017, Cell.

[30]  D. O'Gorman,et al.  Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle , 2017, Diabetes.

[31]  M. Blüher,et al.  The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue , 2017, Nature Medicine.

[32]  C. Kahn,et al.  Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression , 2017, Nature Communications.

[33]  C. Kahn,et al.  Adipose-Derived Circulating miRNAs Regulate Gene Expression in Other Tissues , 2017, Nature.

[34]  M. Karin,et al.  Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction , 2016, Cell.

[35]  Jun Zhu,et al.  Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators. , 2016, Cell metabolism.

[36]  D. Accili,et al.  Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis. , 2016, The Journal of clinical investigation.

[37]  Hongtao Yu,et al.  Mitotic Checkpoint Regulators Control Insulin Signaling and Metabolic Homeostasis , 2016, Cell.

[38]  M. A. Saad,et al.  Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. , 2016, Physiology.

[39]  C. Kahn,et al.  Insulin Resistance in Human iPS Cells Reduces Mitochondrial Size and Function , 2016, Scientific Reports.

[40]  C. Kahn,et al.  Myotubes derived from human-induced pluripotent stem cells mirror in vivo insulin resistance , 2016, Proceedings of the National Academy of Sciences.

[41]  N. Patel,et al.  Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus , 2015, BBA clinical.

[42]  Manolis Kellis,et al.  FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. , 2015, The New England journal of medicine.

[43]  Sean J. Humphrey,et al.  High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics , 2015, Nature Biotechnology.

[44]  C. Kahn,et al.  Role of PKCδ in Insulin Sensitivity and Skeletal Muscle Metabolism , 2015, Diabetes.

[45]  R. DePinho,et al.  FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization , 2015, Nature Communications.

[46]  K. Petersen,et al.  Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes , 2015, Cell.

[47]  Alan Saghatelian,et al.  Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects , 2014, Cell.

[48]  M. Febbraio,et al.  Integrated Control Of Hepatic Lipogenesis Vs. Glucose Production Requires FoxO Transcription Factors , 2014, Nature Communications.

[49]  Wolfgang Wagner,et al.  Epigenetic Rejuvenation of Mesenchymal Stromal Cells Derived from Induced Pluripotent Stem Cells , 2014, Stem cell reports.

[50]  C. Kahn,et al.  Genetic Insulin Resistance Is a Potent Regulator of Gene Expression and Proliferation in Human iPS Cells , 2014, Diabetes.

[51]  H. Himsworth.  Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. 1936. , 2013, International journal of epidemiology.

[52]  David E. James,et al.  Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2 , 2013, Cell metabolism.

[53]  J. Olefsky,et al.  The Origins and Drivers of Insulin Resistance , 2013, Cell.

[54]  Rohit N Kulkarni,et al.  Derivation of Human Induced Pluripotent Stem Cells from Patients with Maturity Onset Diabetes of the Young* , 2013, The Journal of Biological Chemistry.

[55]  M. Fraga,et al.  Genome-Wide Analysis of DNA Methylation Differences in Muscle and Fat from Monozygotic Twins Discordant for Type 2 Diabetes , 2012, PloS one.

[56]  L. Lotti,et al.  JNK2 is activated during ER stress and promotes cell survival , 2012, Cell Death and Disease.

[57]  C. Kahn,et al.  Glypican-4 Enhances Insulin Signaling via Interaction With the Insulin Receptor and Serves as a Novel Adipokine , 2012, Diabetes.

[58]  M. White,et al.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 , 2012, Diabetologia.

[59]  May E. Montasser,et al.  A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance , 2012, Nature Genetics.

[60]  C. Newgard.  Interplay between lipids and branched-chain amino acids in development of insulin resistance. , 2012, Cell metabolism.

[61]  C. Glass,et al.  Inflammation and lipid signaling in the etiology of insulin resistance. , 2012, Cell metabolism.

[62]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[63]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[64]  C. Kahn,et al.  Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 , 2012, Nature Medicine.

[65]  H. Himsworth.  Diabetes mellitus: Its differentiation into insulin‐sensitive and insulin‐insensitive types * , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[66]  M. Laakso,et al.  Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. , 2011, Cell metabolism.

[67]  P. Scherer,et al.  Adipose tissue remodeling and obesity. , 2011, The Journal of clinical investigation.

[68]  G. Hotamışlıgil,et al.  Inflammatory mechanisms in obesity. , 2011, Annual review of immunology.

[69]  Dorothy D. Sears,et al.  Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization , 2009, Proceedings of the National Academy of Sciences.

[70]  J. Zierath,et al.  Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. , 2009, Cell metabolism.

[71]  D. Leroith,et al.  A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. , 2009, The Journal of biological chemistry.

[72]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[73]  Juleen R. Zierath,et al.  Kinetics of GLUT4 Trafficking in Rat and Human Skeletal Muscle , 2009, Diabetes.

[74]  H. Kiyonari,et al.  Forkhead Transcription Factor FoxO1 in Adipose Tissue Regulates Energy Storage and Expenditure , 2008, Diabetes.

[75]  L. Pirola,et al.  Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients , 2008, Diabetologia.

[76]  P. Lebrun,et al.  SOCS proteins causing trouble in insulin action , 2007, Acta physiologica.

[77]  R. DePinho,et al.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.

[78]  S. Carr,et al.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.

[79]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[80]  A. Klip,et al.  Tissue-specific roles of IRS proteins in insulin signaling and glucose transport , 2006, Trends in Endocrinology & Metabolism.

[81]  R. Gougeon,et al.  The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. , 2006, Diabetes.

[82]  C. Kahn,et al.  Critical nodes in signalling pathways: insights into insulin action , 2006, Nature Reviews Molecular Cell Biology.

[83]  E. Schleicher,et al.  The Phosphorylation of Ser318 of Insulin Receptor Substrate 1 Is Not per se Inhibitory in Skeletal Muscle Cells but Is Necessary to Trigger the Attenuation of the Insulin-stimulated Signal* , 2005, Journal of Biological Chemistry.

[84]  S. Kane,et al.  Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. , 2005, Diabetes.

[85]  B. Hemmings,et al.  Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase*♦ , 2004, Journal of Biological Chemistry.

[86]  K. Højlund,et al.  The primary defect in glycogen synthase activity is not based on increased glycogen synthase kinase-3alpha activity in diabetic myotubes. , 2004, Biochemical and biophysical research communications.

[87]  S. Yeaman,et al.  Cultured muscle cells from insulin-resistant type 2 diabetes patients have impaired insulin, but normal 5-amino-4-imidazolecarboxamide riboside-stimulated, glucose uptake. , 2004, The Journal of clinical endocrinology and metabolism.

[88]  E. Schleicher,et al.  Protein Kinase C-ζ-induced Phosphorylation of Ser318 in Insulin Receptor Substrate-1 (IRS-1) Attenuates the Interaction with the Insulin Receptor and the Tyrosine Phosphorylation of IRS-1* , 2004, Journal of Biological Chemistry.

[89]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[90]  D. V. van Aalten,et al.  PDK1, the master regulator of AGC kinase signal transduction. , 2004, Seminars in cell & developmental biology.

[91]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[92]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[93]  K. Nair,et al.  Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Y. Le Marchand-Brustel,et al.  Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.

[95]  John M Asara,et al.  Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation* , 2003, The Journal of Biological Chemistry.

[96]  David J. Kwiatkowski,et al.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[97]  N. Ruderman,et al.  Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .

[98]  P. Poulsen,et al.  The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. , 2002, Diabetes.

[99]  Brian A. Hemmings,et al.  Protein Kinase SGK Mediates Survival Signals by Phosphorylating the Forkhead Transcription Factor FKHRL1 (FOXO3a) , 2001, Molecular and Cellular Biology.

[100]  E. Laurila,et al.  Impaired insulin-stimulated expression of the glycogen synthase gene in skeletal muscle of type 2 diabetic patients is acquired rather than inherited. , 2000, The Journal of clinical endocrinology and metabolism.

[101]  D. Accili,et al.  Differential regulation of gene expression by insulin and IGF‐1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR , 2000, The EMBO journal.

[102]  B. Ursø,et al.  Differences in Signaling Properties of the Cytoplasmic Domains of the Insulin Receptor and Insulin-like Growth Factor Receptor in 3T3-L1 Adipocytes* , 1999, The Journal of Biological Chemistry.

[103]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[104]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[105]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[106]  D. Leroith,et al.  A Molecular Basis for Insulin Resistance , 1997, The Journal of Biological Chemistry.

[107]  Y. Yazaki,et al.  Role of Insulin Receptor Substrate-1 and pp60 in the Regulation of Insulin-induced Glucose Transport and GLUT4 Translocation in Primary Adipocytes* , 1997, The Journal of Biological Chemistry.

[108]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[109]  A. Dunaif,et al.  Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. , 1995, The Journal of clinical investigation.

[110]  R. Shulman,et al.  Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[111]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[112]  I. Godsland,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus , 1992, The Lancet.

[113]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[114]  R. O’Brien,et al.  Regulation of gene expression by insulin. , 1991, Physiological reviews.

[115]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[116]  C. Kahn,et al.  Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system , 1982, Nature.

[117]  G. Smith,et al.  Binding of insulin to isolated nuclei. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[118]  J Roth,et al.  Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[119]  H. Koistinen,et al.  Kinetics of GLUT 4 Trafficking in Rat and Human Skeletal Muscle , 2009 .

[120]  G. Lienhard,et al.  Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. , 2005, Diabetes.

[121]  N. Ruderman,et al.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. , 2002, Diabetes.

[122]  I. Goldfine,et al.  Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. , 2000, Diabetes.

[123]  J. Castaño.  Regulation of gene expression by insulin. , 1991, Advances in enzyme regulation.

[124]  S. Seino,et al.  Structure of the human insulin receptor gene and characterization of its promoter. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[125]  Treatment of Diabetes Mellitus by Pancreatic Extracts. , 2022, Canadian Medical Association journal.

[126]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .